ORAGENICS, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
ORAGENICS, INC. (OGEN) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $46.23 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-03-14
- ORAGENICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $46.23K, a 95.08% decline from fiscal 2022.
- ORAGENICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $940.11K, a 84.58% increase from fiscal 2021.
- ORAGENICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $509.32K, a 54.92% decline from fiscal 2020.
- ORAGENICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $1.13M, a 124.20% increase from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $46.23K 10-K · filed 2025-03-14 |
| 2022-12-31 | $940.11K 10-K · filed 2025-03-14 |
| 2021-12-31 | $509.32K 10-K · filed 2023-04-17 |
| 2020-12-31 | $1.13M 10-K/A · filed 2022-07-29 |
| 2019-12-31 | $503.94K 10-K · filed 2021-03-01 |
| 2018-12-31 | $233.94K 10-K · filed 2020-03-04 |
| 2017-12-31 | $140.31K 10-K · filed 2019-03-29 |
| 2016-12-31 | $166.87K 10-K · filed 2018-02-16 |
| 2015-12-31 | $353.81K 10-K · filed 2017-02-27 |
| 2014-12-31 | $112.87K 10-K · filed 2016-03-30 |
| 2013-12-31 | $361.14K 10-K · filed 2015-02-27 |
| 2012-12-31 | $329.68K 10-K · filed 2014-02-28 |
| 2011-12-31 | $59.97K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |